0000000000088247

AUTHOR

Isabelle Bourdel-marchasson

showing 2 related works from this author

Effect of acetyl-l-carnitine in the treatment of diabetic peripheral neuropathy : A systematic review and meta-analysis

2017

Background/aim: Deficiency of acetyl-L-carnitine (ALC) and L-carnitine (LC) appears to play a role in peripheral diabetic neuropathy, although the evidence in humans is still limited. We conducted a systematic review and meta-analysis investigating the effect of ALC on pain and electromyographic parameters in people with diabetic neuropathy. Methods: A literature search in major databases, without language restriction, was undertaken. Eligible studies were randomized controlled trials (RCTs) or pre-and post-test studies. The effect of ALC supplementation on pain perception and electromyographic parameters in patients with diabetic neuropathy was compared vs. a control group (RCTs). The effe…

medicine.medical_specialtyDiabetic neuropathyDiabetePlaceboNerve conduction velocitylaw.inventionRATS03 medical and health sciencesGLUTAMATE0302 clinical medicineRandomized controlled triallawDiabetes mellitusMedicineQUALITYMeta-analysi030212 general & internal medicineUlnar nerveAdverse effectbusiness.industryDiabetesNERVE GROWTH-FACTORPAINmedicine.diseaseAcetyl-L-carnitine3. Good healthSurgeryNeuropathyAcetyl-L-carnitine; Diabetes; Meta-analysis; Neuropathy; Gerontology; Geriatrics and GerontologyMeta-analysisPeripheral neuropathyAnesthesia3121 General medicine internal medicine and other clinical medicineGeriatrics and GerontologybusinessGerontology030217 neurology & neurosurgeryCLINICAL-TRIALS
researchProduct

Dexamethasone and oxygen therapy in care home residents with diabetes: a management guide and algorithm for treatment: a rapid response action statem…

2021

AbstractThis statement addresses the need to provide clinically relevant and practical guidance for long-term care staff working in care homes and other stakeholders engaged in the care of residents who require consideration for dexamethasone and oxygen therapy. It had been provided following a series of consensus discussions between the EDWPOP and the EuGMS in January and February 2021. Its main aim is to minimise morbidity and mortality from serious acute illnesses including COVID-19 requiring these treatments within the long-term care sector.

Agingmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Statement (logic)medicine.medical_treatmentDiabeteDexamethasone03 medical and health sciencesLong-term care0302 clinical medicineDiabetes mellitusOxygen therapy80 and overDiabetes MellitusMedicineHumans030212 general & internal medicineConsensus DocumentRapid responseAgedGeriatricsAged 80 and overbusiness.industrySARS-CoV-2DiabetesCOVID-19medicine.diseaseCOVID-19 Drug TreatmentOxygenLong-term careAction (philosophy)Family medicineOxygen.Geriatrics and Gerontologybusiness030217 neurology & neurosurgeryAlgorithmsCOVID-19; Dexamethasone; Diabetes; Long-term care; Oxygen; Aged; Aged 80 and over; Algorithms; Dexamethasone; Humans; Oxygen; SARS-CoV-2; COVID-19; Diabetes MellitusAging Clinical and Experimental Research
researchProduct